Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Zydus seeks DCGI nod for Pegylated Interferon alpha-2b to treat COVID-19

expresspharmaApril 06, 2021

Tag: Zydus , COVID-19 , PegIFN , Pegylated Interferon Alpha 2b

PharmaSources Customer Service